Last SFr.82.15 CHF
Change Today +0.15 / 0.18%
Volume 816.4K
NOVN On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 5:46 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Joseph Jimenez MBA

Chief Executive Officer and Member of Executive Committee, Novartis AG
AgeTotal Calculated CompensationThis person is connected to 17 board members in 3 different organizations across 16 different industries.

See Board Relationships
54SFr.13,226,287
As of Fiscal Year 2013

Background*

Mr. Joseph Jimenez, also known as Joe, MBA has been the Chief Executive Officer of Novartis AG since February 1, 2010. Mr. Jimenez serves as the Chief Executive Officer of Novartis International AG. He served as the Chief Executive of Global Pharmaceuticals Business at Novartis Pharmaceuticals Corporation (Novartis Corporation). He served as the Chief Executive Officer of Pharmaceuticals at Novartis AG & Novartis Institutes for BioMedical Research Inc. since October ...

Read Full Background

Corporate Headquarters*

Lichtstrasse 35
Basel, Basel-Stadt 4056

Switzerland

Phone: 41 61 324 11 11
Fax: --

Board Members Memberships*

Former Director and Member of Compensation Committee
Vice President of the Board
Former Director
1999-2004
Former Director
2000-2008
Former Director and Member of Compensation Committee
2003-2007
Former Non-Executive Director, Member of Remuneration Committee and Member of Nomination Committee
2008-N/A
Chairman of the Board
2010-Present
Independent Director, Member of Nominating & Corporate Governance Committee and Member of Finance Committee

Education*

BA 1982
The Leland Stanford Junior University
MBA 1984
University of California Berkeley

Other Affiliations*

Annual Compensation*

SalarySFr.2,055,417
BonusSFr.1,061,200
Total Annual CompensationSFr.3,116,617

Stock Options*

Restricted Stock AwardsSFr.9,839,947
All Other CompensationSFr.269,723
Total Number of Options709,342

Total Compensation*

Total Annual Cash CompensationSFr.3,386,340
Total Short Term CompensationSFr.3,116,617
Other Long Term CompensationSFr.10,109,670
Total Calculated CompensationSFr.13,226,287
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVN:VX SFr.82.15 CHF +0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Alan George Lafley Chairman of the Board, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$1.8M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Kenneth C. Frazier Chairman and Chief Executive Officer
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.